CM
AMGN icon

Crestline Management’s Amgen AMGN Stock Holding History

Crestline Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-60,000
Closed -$14.5M – 38
2019
Q4 		$14.5M Buy
+60,000
New +$13.2M 1.87% 11
2017
Q2 		– Sell
-13,252
Closed -$2.17M – 130
2017
Q1 		$2.17M Buy
+13,252
New +$2.2M 0.4% 28

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Crestline Management's AMGN Position: Q1 2020 in Review

Crestline Management sold out of Amgen (AMGN) in Q1 2020, closing a stake of 60,000 shares — an estimated $14.5M sold.

Crestline Management first reported a position in AMGN in Q1 2017 and held it in 2 quarters. The position peaked at $14.5M in Q4 2019. 2,029 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

  • Crestline Management reported no remaining Amgen position as of Q1 2020 after selling out during the quarter.
  • Crestline Management sold 60,000 Amgen shares in Q1 2020, an estimated $14.5M.
  • Crestline Management first reported a position in Amgen in Q1 2017 and held it in 2 quarters.
  • Crestline Management's Amgen position peaked at $14.5M in Q4 2019.
  • 2,029 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Crestline Management's 13F filing for Q1 2020, filed 13 May 2020.